Biosimilars Follow-on-biologics Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biosimilars & Follow-on-biologics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Human growth hormone
1.2.3 Erythropoietin
1.2.4 Monoclonal antibodies
1.2.5 Insulin
1.2.6 Interferon
1.2.7 Granulocyte-Colony Stimulating Factor
1.2.8 Others
1.3 Market by Application
1.3.1 Global Biosimilars & Follow-on-biologics Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Blood Disorders
1.3.3 Oncology Diseases
1.3.4 Chronic and Autoimmune Diseases
1.3.5 Growth Hormone Deficiencies
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biosimilars & Follow-on-biologics Market Perspective (2017-2028)
2.2 Biosimilars & Follow-on-biologics Growth Trends by Region
2.2.1 Biosimilars & Follow-on-biologics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Biosimilars & Follow-on-biologics Historic Market Size by Region (2017-2022)
2.2.3 Biosimilars & Follow-on-biologics Forecasted Market Size by Region (2023-2028)
2.3 Biosimilars & Follow-on-biologics Market Dynamics
2.3.1 Biosimilars & Follow-on-biologics Industry Trends
2.3.2 Biosimilars & Follow-on-biologics Market Drivers
2.3.3 Biosimilars & Follow-on-biologics Market Challenges
2.3.4 Biosimilars & Follow-on-biologics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biosimilars & Follow-on-biologics Players by Revenue
3.1.1 Global Top Biosimilars & Follow-on-biologics Players by Revenue (2017-2022)
3.1.2 Global Biosimilars & Follow-on-biologics Revenue Market Share by Players (2017-2022)
3.2 Global Biosimilars & Follow-on-biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biosimilars & Follow-on-biologics Revenue
3.4 Global Biosimilars & Follow-on-biologics Market Concentration Ratio
3.4.1 Global Biosimilars & Follow-on-biologics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biosimilars & Follow-on-biologics Revenue in 2021
3.5 Biosimilars & Follow-on-biologics Key Players Head office and Area Served
3.6 Key Players Biosimilars & Follow-on-biologics Product Solution and Service
3.7 Date of Enter into Biosimilars & Follow-on-biologics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biosimilars & Follow-on-biologics Breakdown Data by Type
4.1 Global Biosimilars & Follow-on-biologics Historic Market Size by Type (2017-2022)
4.2 Global Biosimilars & Follow-on-biologics Forecasted Market Size by Type (2023-2028)
5 Biosimilars & Follow-on-biologics Breakdown Data by Application
5.1 Global Biosimilars & Follow-on-biologics Historic Market Size by Application (2017-2022)
5.2 Global Biosimilars & Follow-on-biologics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Biosimilars & Follow-on-biologics Market Size (2017-2028)
6.2 North America Biosimilars & Follow-on-biologics Market Size by Country (2017-2022)
6.3 North America Biosimilars & Follow-on-biologics Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Biosimilars & Follow-on-biologics Market Size (2017-2028)
7.2 Europe Biosimilars & Follow-on-biologics Market Size by Country (2017-2022)
7.3 Europe Biosimilars & Follow-on-biologics Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biosimilars & Follow-on-biologics Market Size (2017-2028)
8.2 Asia-Pacific Biosimilars & Follow-on-biologics Market Size by Country (2017-2022)
8.3 Asia-Pacific Biosimilars & Follow-on-biologics Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Biosimilars & Follow-on-biologics Market Size (2017-2028)
9.2 Latin America Biosimilars & Follow-on-biologics Market Size by Country (2017-2022)
9.3 Latin America Biosimilars & Follow-on-biologics Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biosimilars & Follow-on-biologics Market Size (2017-2028)
10.2 Middle East & Africa Biosimilars & Follow-on-biologics Market Size by Country (2017-2022)
10.3 Middle East & Africa Biosimilars & Follow-on-biologics Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Novartis (Sandoz)
11.1.1 Novartis (Sandoz) Company Detail
11.1.2 Novartis (Sandoz) Business Overview
11.1.3 Novartis (Sandoz) Biosimilars & Follow-on-biologics Introduction
11.1.4 Novartis (Sandoz) Revenue in Biosimilars & Follow-on-biologics Business (2017-2022)
11.1.5 Novartis (Sandoz) Recent Development
11.2 Synthon Pharmaceuticals
11.2.1 Synthon Pharmaceuticals Company Detail
11.2.2 Synthon Pharmaceuticals Business Overview
11.2.3 Synthon Pharmaceuticals Biosimilars & Follow-on-biologics Introduction
11.2.4 Synthon Pharmaceuticals Revenue in Biosimilars & Follow-on-biologics Business (2017-2022)
11.2.5 Synthon Pharmaceuticals Recent Development
11.3 Teva Pharmaceutical Industries
11.3.1 Teva Pharmaceutical Industries Company Detail
11.3.2 Teva Pharmaceutical Industries Business Overview
11.3.3 Teva Pharmaceutical Industries Biosimilars & Follow-on-biologics Introduction
11.3.4 Teva Pharmaceutical Industries Revenue in Biosimilars & Follow-on-biologics Business (2017-2022)
11.3.5 Teva Pharmaceutical Industries Recent Development
11.4 LG Life Sciences
11.4.1 LG Life Sciences Company Detail
11.4.2 LG Life Sciences Business Overview
11.4.3 LG Life Sciences Biosimilars & Follow-on-biologics Introduction
11.4.4 LG Life Sciences Revenue in Biosimilars & Follow-on-biologics Business (2017-2022)
11.4.5 LG Life Sciences Recent Development
11.5 Celltrion Biocon
11.5.1 Celltrion Biocon Company Detail
11.5.2 Celltrion Biocon Business Overview
11.5.3 Celltrion Biocon Biosimilars & Follow-on-biologics Introduction
11.5.4 Celltrion Biocon Revenue in Biosimilars & Follow-on-biologics Business (2017-2022)
11.5.5 Celltrion Biocon Recent Development
11.6 Hospira
11.6.1 Hospira Company Detail
11.6.2 Hospira Business Overview
11.6.3 Hospira Biosimilars & Follow-on-biologics Introduction
11.6.4 Hospira Revenue in Biosimilars & Follow-on-biologics Business (2017-2022)
11.6.5 Hospira Recent Development
11.7 Merck Serono (Merck)
11.7.1 Merck Serono (Merck) Company Detail
11.7.2 Merck Serono (Merck) Business Overview
11.7.3 Merck Serono (Merck) Biosimilars & Follow-on-biologics Introduction
11.7.4 Merck Serono (Merck) Revenue in Biosimilars & Follow-on-biologics Business (2017-2022)
11.7.5 Merck Serono (Merck) Recent Development
11.8 Biogen idec
11.8.1 Biogen idec Company Detail
11.8.2 Biogen idec Business Overview
11.8.3 Biogen idec Biosimilars & Follow-on-biologics Introduction
11.8.4 Biogen idec Revenue in Biosimilars & Follow-on-biologics Business (2017-2022)
11.8.5 Biogen idec Recent Development
11.9 Genentech (Roche)
11.9.1 Genentech (Roche) Company Detail
11.9.2 Genentech (Roche) Business Overview
11.9.3 Genentech (Roche) Biosimilars & Follow-on-biologics Introduction
11.9.4 Genentech (Roche) Revenue in Biosimilars & Follow-on-biologics Business (2017-2022)
11.9.5 Genentech (Roche) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Biosimilars & Follow-on-biologics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Human growth hormone
Table 3. Key Players of Erythropoietin
Table 4. Key Players of Monoclonal antibodies
Table 5. Key Players of Insulin
Table 6. Key Players of Interferon
Table 7. Key Players of Granulocyte-Colony Stimulating Factor
Table 8. Key Players of Others
Table 9. Global Biosimilars & Follow-on-biologics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 10. Global Biosimilars & Follow-on-biologics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 11. Global Biosimilars & Follow-on-biologics Market Size by Region (2017-2022) & (US$ Million)
Table 12. Global Biosimilars & Follow-on-biologics Market Share by Region (2017-2022)
Table 13. Global Biosimilars & Follow-on-biologics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 14. Global Biosimilars & Follow-on-biologics Market Share by Region (2023-2028)
Table 15. Biosimilars & Follow-on-biologics Market Trends
Table 16. Biosimilars & Follow-on-biologics Market Drivers
Table 17. Biosimilars & Follow-on-biologics Market Challenges
Table 18. Biosimilars & Follow-on-biologics Market Restraints
Table 19. Global Biosimilars & Follow-on-biologics Revenue by Players (2017-2022) & (US$ Million)
Table 20. Global Biosimilars & Follow-on-biologics Market Share by Players (2017-2022)
Table 21. Global Top Biosimilars & Follow-on-biologics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilars & Follow-on-biologics as of 2021)
Table 22. Ranking of Global Top Biosimilars & Follow-on-biologics Companies by Revenue (US$ Million) in 2021
Table 23. Global 5 Largest Players Market Share by Biosimilars & Follow-on-biologics Revenue (CR5 and HHI) & (2017-2022)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Biosimilars & Follow-on-biologics Product Solution and Service
Table 26. Date of Enter into Biosimilars & Follow-on-biologics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Biosimilars & Follow-on-biologics Market Size by Type (2017-2022) & (US$ Million)
Table 29. Global Biosimilars & Follow-on-biologics Revenue Market Share by Type (2017-2022)
Table 30. Global Biosimilars & Follow-on-biologics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 31. Global Biosimilars & Follow-on-biologics Revenue Market Share by Type (2023-2028)
Table 32. Global Biosimilars & Follow-on-biologics Market Size by Application (2017-2022) & (US$ Million)
Table 33. Global Biosimilars & Follow-on-biologics Revenue Market Share by Application (2017-2022)
Table 34. Global Biosimilars & Follow-on-biologics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 35. Global Biosimilars & Follow-on-biologics Revenue Market Share by Application (2023-2028)
Table 36. North America Biosimilars & Follow-on-biologics Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Biosimilars & Follow-on-biologics Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Biosimilars & Follow-on-biologics Market Size by Country (2017-2022) & (US$ Million)
Table 39. Europe Biosimilars & Follow-on-biologics Market Size by Country (2023-2028) & (US$ Million)
Table 40. Asia-Pacific Biosimilars & Follow-on-biologics Market Size by Region (2017-2022) & (US$ Million)
Table 41. Asia-Pacific Biosimilars & Follow-on-biologics Market Size by Region (2023-2028) & (US$ Million)
Table 42. Latin America Biosimilars & Follow-on-biologics Market Size by Country (2017-2022) & (US$ Million)
Table 43. Latin America Biosimilars & Follow-on-biologics Market Size by Country (2023-2028) & (US$ Million)
Table 44. Middle East & Africa Biosimilars & Follow-on-biologics Market Size by Country (2017-2022) & (US$ Million)
Table 45. Middle East & Africa Biosimilars & Follow-on-biologics Market Size by Country (2023-2028) & (US$ Million)
Table 46. Novartis (Sandoz) Company Detail
Table 47. Novartis (Sandoz) Business Overview
Table 48. Novartis (Sandoz) Biosimilars & Follow-on-biologics Product
Table 49. Novartis (Sandoz) Revenue in Biosimilars & Follow-on-biologics Business (2017-2022) & (US$ Million)
Table 50. Novartis (Sandoz) Recent Development
Table 51. Synthon Pharmaceuticals Company Detail
Table 52. Synthon Pharmaceuticals Business Overview
Table 53. Synthon Pharmaceuticals Biosimilars & Follow-on-biologics Product
Table 54. Synthon Pharmaceuticals Revenue in Biosimilars & Follow-on-biologics Business (2017-2022) & (US$ Million)
Table 55. Synthon Pharmaceuticals Recent Development
Table 56. Teva Pharmaceutical Industries Company Detail
Table 57. Teva Pharmaceutical Industries Business Overview
Table 58. Teva Pharmaceutical Industries Biosimilars & Follow-on-biologics Product
Table 59. Teva Pharmaceutical Industries Revenue in Biosimilars & Follow-on-biologics Business (2017-2022) & (US$ Million)
Table 60. Teva Pharmaceutical Industries Recent Development
Table 61. LG Life Sciences Company Detail
Table 62. LG Life Sciences Business Overview
Table 63. LG Life Sciences Biosimilars & Follow-on-biologics Product
Table 64. LG Life Sciences Revenue in Biosimilars & Follow-on-biologics Business (2017-2022) & (US$ Million)
Table 65. LG Life Sciences Recent Development
Table 66. Celltrion Biocon Company Detail
Table 67. Celltrion Biocon Business Overview
Table 68. Celltrion Biocon Biosimilars & Follow-on-biologics Product
Table 69. Celltrion Biocon Revenue in Biosimilars & Follow-on-biologics Business (2017-2022) & (US$ Million)
Table 70. Celltrion Biocon Recent Development
Table 71. Hospira Company Detail
Table 72. Hospira Business Overview
Table 73. Hospira Biosimilars & Follow-on-biologics Product
Table 74. Hospira Revenue in Biosimilars & Follow-on-biologics Business (2017-2022) & (US$ Million)
Table 75. Hospira Recent Development
Table 76. Merck Serono (Merck) Company Detail
Table 77. Merck Serono (Merck) Business Overview
Table 78. Merck Serono (Merck) Biosimilars & Follow-on-biologics Product
Table 79. Merck Serono (Merck) Revenue in Biosimilars & Follow-on-biologics Business (2017-2022) & (US$ Million)
Table 80. Merck Serono (Merck) Recent Development
Table 81. Biogen idec Company Detail
Table 82. Biogen idec Business Overview
Table 83. Biogen idec Biosimilars & Follow-on-biologics Product
Table 84. Biogen idec Revenue in Biosimilars & Follow-on-biologics Business (2017-2022) & (US$ Million)
Table 85. Biogen idec Recent Development
Table 86. Genentech (Roche) Company Detail
Table 87. Genentech (Roche) Business Overview
Table 88. Genentech (Roche) Biosimilars & Follow-on-biologics Product
Table 89. Genentech (Roche) Revenue in Biosimilars & Follow-on-biologics Business (2017-2022) & (US$ Million)
Table 90. Genentech (Roche) Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biosimilars & Follow-on-biologics Market Share by Type: 2021 VS 2028
Figure 2. Human growth hormone Features
Figure 3. Erythropoietin Features
Figure 4. Monoclonal antibodies Features
Figure 5. Insulin Features
Figure 6. Interferon Features
Figure 7. Granulocyte-Colony Stimulating Factor Features
Figure 8. Others Features
Figure 9. Global Biosimilars & Follow-on-biologics Market Share by Application in 2021 & 2028
Figure 10. Blood Disorders Case Studies
Figure 11. Oncology Diseases Case Studies
Figure 12. Chronic and Autoimmune Diseases Case Studies
Figure 13. Growth Hormone Deficiencies Case Studies
Figure 14. Others Case Studies
Figure 15. Biosimilars & Follow-on-biologics Report Years Considered
Figure 16. Global Biosimilars & Follow-on-biologics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 17. Global Biosimilars & Follow-on-biologics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 18. Global Biosimilars & Follow-on-biologics Market Share by Region: 2021 VS 2028
Figure 19. Global Biosimilars & Follow-on-biologics Market Share by Players in 2021
Figure 20. Global Top Biosimilars & Follow-on-biologics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilars & Follow-on-biologics as of 2021)
Figure 21. The Top 10 and 5 Players Market Share by Biosimilars & Follow-on-biologics Revenue in 2021
Figure 22. North America Biosimilars & Follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. North America Biosimilars & Follow-on-biologics Market Share by Country (2017-2028)
Figure 24. United States Biosimilars & Follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Canada Biosimilars & Follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Europe Biosimilars & Follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Europe Biosimilars & Follow-on-biologics Market Share by Country (2017-2028)
Figure 28. Germany Biosimilars & Follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Biosimilars & Follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Biosimilars & Follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Biosimilars & Follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Biosimilars & Follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Biosimilars & Follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Biosimilars & Follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Asia-Pacific Biosimilars & Follow-on-biologics Market Share by Region (2017-2028)
Figure 36. China Biosimilars & Follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Biosimilars & Follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Biosimilars & Follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Biosimilars & Follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Biosimilars & Follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Biosimilars & Follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Latin America Biosimilars & Follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Latin America Biosimilars & Follow-on-biologics Market Share by Country (2017-2028)
Figure 44. Mexico Biosimilars & Follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Brazil Biosimilars & Follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Middle East & Africa Biosimilars & Follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Biosimilars & Follow-on-biologics Market Share by Country (2017-2028)
Figure 48. Turkey Biosimilars & Follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Saudi Arabia Biosimilars & Follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Novartis (Sandoz) Revenue Growth Rate in Biosimilars & Follow-on-biologics Business (2017-2022)
Figure 51. Synthon Pharmaceuticals Revenue Growth Rate in Biosimilars & Follow-on-biologics Business (2017-2022)
Figure 52. Teva Pharmaceutical Industries Revenue Growth Rate in Biosimilars & Follow-on-biologics Business (2017-2022)
Figure 53. LG Life Sciences Revenue Growth Rate in Biosimilars & Follow-on-biologics Business (2017-2022)
Figure 54. Celltrion Biocon Revenue Growth Rate in Biosimilars & Follow-on-biologics Business (2017-2022)
Figure 55. Hospira Revenue Growth Rate in Biosimilars & Follow-on-biologics Business (2017-2022)
Figure 56. Merck Serono (Merck) Revenue Growth Rate in Biosimilars & Follow-on-biologics Business (2017-2022)
Figure 57. Biogen idec Revenue Growth Rate in Biosimilars & Follow-on-biologics Business (2017-2022)
Figure 58. Genentech (Roche) Revenue Growth Rate in Biosimilars & Follow-on-biologics Business (2017-2022)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Industry Market Size
